Keywords
Last Name

Richard Laing, MBChB, MSc (CHDC) MD

TitleProfessor
InstitutionBoston University School of Public Health
DepartmentGlobal Health
Phone(617) 414-1445
 Awards and Honors

Start-EndDescription
2009Utrecht University: Honorary degree Doctoris Honoris Causae
1984-1985Commonwealth Secretariat: Commonwealth Fellowship
1985-1986Beit Trust: Beit Fellowship
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Rockers PC, Wirtz VJ, Umeh CA, Swamy PM, Laing RO. Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence. Health Aff (Millwood). 2017 Apr 01; 36(4):706-713. PMID: 28373337.
    View in: PubMed
  2. Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases. PLoS One. 2017; 12(2):e0171284. PMID: 28170413.
    View in: PubMed
  3. Rockers PC, Wirtz VJ, Vian T, Onyango MA, Ashigbie PG, Laing R. Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya. BMJ Open. 2016 Nov 25; 6(11):e013386. PMID: 27888177.
    View in: PubMed
  4. Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries". Circulation. 2016 Oct 04; 134(14):e305-e306. PMID: 27698055.
    View in: PubMed
  5. Beran D, Ewen M, Laing R. Insulin in 2016: Challenge and constraints to access. Diabetes Res Clin Pract. 2016 Jul; 117:119-21. PMID: 27329030.
    View in: PubMed
  6. Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation. 2016 May 24; 133(21):2076-85. PMID: 27217433.
    View in: PubMed
  7. Sharma A, Rorden L, Ewen M, Laing R. Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology. J Pharm Policy Pract. 2016; 9:12. PMID: 27054040.
    View in: PubMed
  8. Beran D, Ewen M, Laing R. Constraints and challenges in access to insulin: a global perspective. Lancet Diabetes Endocrinol. 2016 Mar; 4(3):275-85. PMID: 26857998.
    View in: PubMed
  9. Kaplan W, Laing R, Ewen M, Beran D. Insulin patents and market exclusivities: unresolved issues. Lancet Diabetes Endocrinol. 2016 Feb; 4(2):98. PMID: 26825233.
    View in: PubMed
  10. Hazel Bradley, Siraaj Adams, Ricardo Kettledas, Tania Mathys, Margaret von Zeil, Richard Laing. Innovations to improve access to and use of medicines for chronic conditions. South African Pharmacy Journal. 2016; 83(5):36-40.
  11. Cañigueral-Vila N, Chen JC, Frenkel-Rorden L, Laing R. Improvements for international medicine donations: a review of the World Health Organization Guidelines for Medicine Donations, 3rd edition. J Pharm Policy Pract. 2015; 8:28. PMID: 26525948.
    View in: PubMed
  12. Bradley H, Laing R. Access to medicines - overcoming the barriers. East Mediterr Health J. 2015 Sep 28; 21(8):553-4. PMID: 26446525.
    View in: PubMed
  13. Bukhman G, Bavuma C, Gishoma C, Gupta N, Kwan GF, Laing R, Beran D. Endemic diabetes in the world's poorest people. Lancet Diabetes Endocrinol. 2015 Jun; 3(6):402-3. PMID: 26003752.
    View in: PubMed
  14. Bigdeli M, Laing R, Tomson G, Babar ZU. Medicines and universal health coverage: challenges and opportunities. J Pharm Policy Pract. 2015; 8(1):8. PMID: 25825675.
    View in: PubMed
  15. Tobin, M. R., & Laing, R. Generic medicine: Boston University students’ perceptions and surprising lack of knowledge. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 2015; 3-4(11):136-145.
    View in: External Website
  16. Ewen M, Al Sakit M, Saadeh R, Laing R, Vialle-Valentin C, Seita A, Bunders J. Comparative assessment of medicine procurement prices in the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA). J Pharm Policy Pract. 2014; 7(1):13. PMID: 25379183.
    View in: PubMed
  17. Leopold C, Mantel-Teeuwisse AK, Vogler S, Valkova S, de Joncheere K, Leufkens HG, Wagner AK, Ross-Degnan D, Laing R. Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries. Bull World Health Organ. 2014 Sep 1; 92(9):630-640D. PMID: 25378754.
    View in: PubMed
  18. Tafuri G, Stolk P, Trotta F, Putzeist M, Leufkens HG, Laing RO, De Allegri M. How do the EMA and FDA decide which anticancer drugs make it to the market? A comparative qualitative study on decision makers' views. Ann Oncol. 2014 Jan; 25(1):265-9. PMID: 24356637.
    View in: PubMed
  19. Bigdeli M, Javadi D, Hoebert J, Laing R, Ranson K. Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries. Health Res Policy Syst. 2013; 11:37. PMID: 24124696.
    View in: PubMed
  20. Leopold C, Mantel-Teeuwisse AK, Vogler S, de Joncheere K, Laing RO, Leufkens HG. Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries. Health Policy. 2013 Oct; 112(3):209-16. PMID: 24060335.
    View in: PubMed
  21. Hoebert JM, van Dijk L, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. National medicines policies - a review of the evolution and development processes. J Pharm Policy Pract. 2013; 6:5. PMID: 24764540.
    View in: PubMed
  22. Barber SL, Huang B, Santoso B, Laing R, Paris V, Wu C. The reform of the essential medicines system in China: a comprehensive approach to universal coverage. J Glob Health. 2013 Jun; 3(1):010303. PMID: 23826503.
    View in: PubMed
  23. Björkhem-Bergman L, Andersén-Karlsson E, Laing R, Diogene E, Melien O, Jirlow M, Malmström RE, Vogler S, Godman B, Gustafsson LL. Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. Eur J Clin Pharmacol. 2013 May; 69 Suppl 1:73-8. PMID: 23640191.
    View in: PubMed
  24. Leopold C, Mantel-Teeuwisse AK, Seyfang L, Vogler S, de Joncheere K, Laing RO, Leufkens H. Impact of external price referencing on medicine prices - a price comparison among 14 European countries. South Med Rev. 2012 Dec; 5(2):34-41. PMID: 23532710.
    View in: PubMed
  25. Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, Van Damme W. Access to medicines from a health system perspective. Health Policy Plan. 2013 Oct; 28(7):692-704. PMID: 23174879.
    View in: PubMed
  26. Cameron A, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health. 2012 Jul-Aug; 15(5):664-73. PMID: 22867775.
    View in: PubMed
  27. Leopold C, Vogler S, Mantel-Teeuwisse AK, de Joncheere K, Leufkens HG, Laing R. Differences in external price referencing in Europe: a descriptive overview. Health Policy. 2012 Jan; 104(1):50-60. PMID: 22014843.
    View in: PubMed
  28. Trotta F, Leufkens HG, Schellens JH, Laing R, Tafuri G. Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: when differences have an impact on clinical practice. J Clin Oncol. 2011 Jun 1; 29(16):2266-72. PMID: 21537038.
    View in: PubMed
  29. Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ. 2011 Jun 1; 89(6):412-21. PMID: 21673857.
    View in: PubMed
  30. Hoebert JM, Mantel-Teeuwisse AK, van Dijk L, Laing RO, Leufkens HG. Quality and completeness of utilisation data on biological agents across European countries: tumour necrosis factor alpha inhibitors as a case study. Pharmacoepidemiol Drug Saf. 2011 Mar; 20(3):265-71. PMID: 21351308.
    View in: PubMed
  31. Perehudoff SK, Laing RO, Hogerzeil HV. Access to essential medicines in national constitutions. Bull World Health Organ. 2010 Nov 1; 88(11):800. PMID: 21076556.
    View in: PubMed
  32. Niëns LM, Cameron A, Van de Poel E, Ewen M, Brouwer WB, Laing R. Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world. PLoS Med. 2010; 7(8). PMID: 20824175.
    View in: PubMed
  33. van Mourik MS, Cameron A, Ewen M, Laing RO. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010; 10:25. PMID: 20534118.
    View in: PubMed
  34. Madden JM, Meza E, Ewen M, Laing RO, Stephens P, Ross-Degnan D. Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology. Rev Panam Salud Publica. 2010 Apr; 27(4):291-9. PMID: 20512232.
    View in: PubMed
  35. Ritz LS, Adam T, Laing R. A bibliometric study of publication patterns in access to medicines research in developing countries. South Med Rev. 2010 Feb; 3(1):2-6. PMID: 23093876.
    View in: PubMed
  36. Chalker J, Wagner A, Tomson G, Laing R, Johnson K, Wahlström R, Ross-Degnan D. Urgent need for coordination in adopting standardized antiretroviral adherence performance indicators. J Acquir Immune Defic Syndr. 2010 Feb; 53(2):159-61. PMID: 19861899.
    View in: PubMed
  37. Tafuri G, Leufkens HG, Laing R, Trotta F. Therapeutic indications in oncology: emerging features and regulatory dynamics. Eur J Cancer. 2010 Feb; 46(3):471-5. PMID: 20056536.
    View in: PubMed
  38. Waning B, Maddix J, Tripodis Y, Laing R, Leufkens HG, Gokhale M. Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan. Int J Equity Health. 2009; 8:43. PMID: 20003422.
    View in: PubMed
  39. Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A, Raman K, Singhal GL, Thawani V, Tripathi S, Laing R. Prices & availability of common medicines at six sites in India using a standard methodology. Indian J Med Res. 2007 May; 125(5):645-54. PMID: 17642500.
    View in: PubMed
  40. Mendis S, Fukino K, Cameron A, Laing R, Filipe A, Khatib O, Leowski J, Ewen M. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007 Apr; 85(4):279-88. PMID: 17546309.
    View in: PubMed
  41. Laing R, Vrakking H, Fourie B. Quality and stability of TB medicines: let the buyer beware! Int J Tuberc Lung Dis. 2004 Sep; 8(9):1043-4. PMID: 15455587.
    View in: PubMed
  42. Laing R. EQA for AFB smear microscopy manual. Int J Tuberc Lung Dis. 2004 Jul; 8(7):920; authors reply 920-1. PMID: 15260289.
    View in: PubMed
  43. Kaplan WA, Laing R. Paying for pharmaceutical registration in developing countries. Health Policy Plan. 2003 Sep; 18(3):237-48. PMID: 12917265.
    View in: PubMed
  44. Laing R, Waning B, Gray A, Ford N, 't Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003 May 17; 361(9370):1723-9. PMID: 12767751.
    View in: PubMed
  45. Laing R. Whose interests does the World Trade Organization serve? Lancet. 2003 Apr 12; 361(9365):1297. PMID: 12699973.
    View in: PubMed
  46. Pavin M, Nurgozhin T, Hafner G, Yusufy F, Laing R. Prescribing practices of rural primary health care physicians in Uzbekistan. Trop Med Int Health. 2003 Feb; 8(2):182-90. PMID: 12581446.
    View in: PubMed
  47. Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet. 2002 Jun 22; 359(9324):2188-94. PMID: 12090998.
    View in: PubMed
  48. Laing R, Hogerzeil H, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan. 2001 Mar; 16(1):13-20. PMID: 11238425.
    View in: PubMed
  49. Laing RO, McGoldrick KM. Tuberculosis drug issues: prices, fixed-dose combination products and second-line drugs. Int J Tuberc Lung Dis. 2000 Dec; 4(12 Suppl 2):S194-207. PMID: 11144553.
    View in: PubMed
  50. Laing RO, Ross-Degnan DG. National drug policies. Lancet. 1995 Dec 9; 346(8989):1561-2. PMID: 7491072.
    View in: PubMed
  51. Massele AY, Sayi J, Nsimba SE, Ofori-Adjei D, Laing RO. Knowledge and management of malaria in Dar es Salaam, Tanzania. East Afr Med J. 1993 Oct; 70(10):639-42. PMID: 8187661.
    View in: PubMed
  52. Massele AY, Ofori-Adjei D, Laing RO. A study of prescribing patterns with special reference to drug use indicators in Dar es Salaam Region, Tanzania. Trop Doct. 1993 Jul; 23(3):104-7. PMID: 8356735.
    View in: PubMed
  53. Laing RO, Todd CH. Postgraduate district hospital training in Zambia. Lancet. 1993 Apr 10; 341(8850):966. PMID: 8096305.
    View in: PubMed
  54. Howard NJ, Laing RO. Changes in the World Health Organisation essential drug list. Lancet. 1991 Sep 21; 338(8769):743-5. PMID: 1679879.
    View in: PubMed
  55. Quick JD, Laing RO, Ross-Degnan DG. Intervention research to promote clinically effective and economically efficient use of pharmaceuticals: the International Network for Rational Use of Drugs. J Clin Epidemiol. 1991; 44 Suppl 2:57S-65S. PMID: 2045843.
    View in: PubMed
  56. Laing RO. Rational drug use: an unsolved problem. Trop Doct. 1990 Jul; 20(3):101-3. PMID: 2219416.
    View in: PubMed
  57. Laing RO. International Network for the Rational Use of Drugs (INRUD) Trop Doct. 1990 Jul; 20(3):133-4. PMID: 2219430.
    View in: PubMed
Richard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department